Matthew Elmes holds a Ph.D. in Molecular and Cellular Biology from Stony Brook University, where he focused on endocannabinoid and phytocannabinoid cellular transport mechanisms for his dissertation work. By the end of his graduate education he had authored over a dozen peer-reviewed scientific journal articles about cannabinoids and was a co-inventor two patents related to cannabinoids. 

In 2018 Dr. Elmes began his postdoctoral work in biopharma with Artelo Biosciences developing a novel class of endocannabinoid transport inhibitors. The compounds that he and his team developed are able to modulate endocannabinoid system signaling and hold great promise as non-addictive, anti-inflammatory and pain-killing drugs. 

Dr. Elmes next transitioned to a position in the California cannabis industry. He is currently the Director of Scientific Affairs for CannaCraft, one of the largest cannabis product manufacturers in the world, where he focuses on cannabis education, formulations and product development for CannaCraft’s brands Satori, AbsoluteXtracts, and Care by Design.